Antibiotic targeting of the bacterial secretory pathway

被引:46
作者
Rao, Smitha C., V [1 ]
De Waelheyns, Evelien [1 ]
Economou, Anastassios [1 ,2 ,3 ]
Anne, Jozef [1 ]
机构
[1] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Lab Mol Bacteriol, B-3000 Leuven, Belgium
[2] Univ Crete, FORTH, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Crete, Greece
[3] Univ Crete, Dept Biol, GR-71110 Iraklion, Crete, Greece
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2014年 / 1843卷 / 08期
关键词
Antibiotic target; Protein secretion inhibitor; Signal peptidase; SecA; Antibiotic resistance; I SIGNAL PEPTIDASE; COLI LEADER PEPTIDASE; CANDIDATUS LIBERIBACTER ASIATICUS; TWIN-ARGININE TRANSLOCASE; STREPTOMYCES SP TU-6075; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN SECRETION; CRYSTAL-STRUCTURE; PREPROTEIN TRANSLOCASE;
D O I
10.1016/j.bbamcr.2014.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Finding new, effective antibiotics is a challenging research area driven by novel approaches required to tackle unconventional targets. In this review we focus on the bacterial protein secretion pathway as a target for eliminating or disarming pathogens. We discuss the latest developments in targeting the Sec-pathway for novel antibiotics focusing on two key components: SecA, the ATP-driven motor protein responsible for driving preproteins across the cytoplasmic membrane and the Type I signal peptidase that is responsible for the removal of the signal peptide allowing the release of the mature protein from the membrane. We take a bird's-eye view of other potential targets in the Sec-pathway as well as other Sec-dependent or Sec-independent protein secretion pathways as targets for the development of novel antibiotics. This article is part of a Special Issue entitled: Protein trafficking and secretion in bacteria. Guest Editors: Anastassios Economou and Ross Dalbey. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:1762 / 1783
页数:22
相关论文
共 197 条
  • [1] Systematic identification of essential genes by in vitro mariner mutagenesis
    Akerley, BJ
    Rubin, EJ
    Camilli, A
    Lampe, DJ
    Robertson, HM
    Mekalanos, JJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8927 - 8932
  • [2] Identification of small molecule inhibitors against SecA of Candidatus Liberibacter asiaticus by structure based design
    Akula, Nagaraju
    Trivedi, Pankaj
    Han, Frank Q.
    Wang, Nian
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 54 : 919 - 924
  • [3] Discovery of novel SecA inhibitors of Candidatus Liberibacter asiaticus by structure based design
    Akula, Nagaraju
    Zheng, Hong
    Han, Frank Q.
    Wang, Nian
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4183 - 4188
  • [4] Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system
    Alksne, LE
    Burgio, P
    Hu, W
    Feld, B
    Singh, MP
    Tuckman, M
    Petersen, PJ
    Labthavikul, P
    McGlynn, M
    Barbieri, L
    McDonald, L
    Bradford, P
    Dushin, RG
    Rothstein, D
    Projan, SJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1418 - 1427
  • [5] Inhibitors of bacterial signal peptidase: A series of 6-(substituted oxyethyl)penems
    Allsop, A
    Brooks, G
    Edwards, PD
    Kaura, AC
    Southgate, R
    [J]. JOURNAL OF ANTIBIOTICS, 1996, 49 (09) : 921 - 928
  • [6] Allsop A.E., 1997, ANTIINFECTIVES RECEN
  • [7] PENEM INHIBITORS OF BACTERIAL SIGNAL PEPTIDASE
    ALLSOP, AE
    BROOKS, G
    BRUTON, G
    COULTON, S
    EDWARDS, PD
    HATTON, IK
    KAURA, AC
    MCLEAN, SD
    PEARSON, ND
    SMALE, TC
    SOUTHGATE, R
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (05) : 443 - 448
  • [8] Race against time to develop new antibiotics
    不详
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2011, 89 (02) : 88 - 89
  • [9] [Anonymous], EV THREAT ANT RES OP
  • [10] [Anonymous], ANN REPORT CHIEF MED